Evidence map›Paper›PMID 35320462›Full record

ArticleJournal of molecular neuroscience : MN2022

Acetyl-L-Carnitine Exerts Neuroprotective and Anticonvulsant Effect in Kainate Murine Model of Temporal Lobe Epilepsy.

Mahsa Tashakori-Miyanroudi, Samira Ramazi, Paria Hashemi, Morteza Nazari-Serenjeh, Tourandokht Baluchnejadmojarad, Mehrdad Roghani

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Research progress on oxidative stress regulating different types of neuronal death caused by epileptic seizures.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mahsa Tashakori-MiyanroudiStudent Research Committee, Iran University of Medical Sciences, Tehran, Iran.
Samira RamaziStudent Research Committee, Iran University of Medical Sciences, Tehran, Iran.
Paria HashemiStudent Research Committee, Iran University of Medical Sciences, Tehran, Iran.
Morteza Nazari-SerenjehStudent Research Committee, Iran University of Medical Sciences, Tehran, Iran.
Tourandokht BaluchnejadmojaradDepartment of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. tmojarad@yahoo.com.ORCID http://orcid.org/0000-0002-2703-728X
Mehrdad RoghaniNeurophysiology Research Center, Shahed University, Tehran, Iran.
Iran University of Medical Sciences · IRShahed University · IR

Funding

Iran University of Medical Sciences 97-03-04-12735
6 · The paper itself

Abstract

The most well-known type of focal epilepsy that is resistant to existing treatments is temporal lobe epilepsy (TLE), with seizure foci in various structures including temporal lobe, hippocampus, amygdala, entorhinal cortex, and subcortex. The most significant processes involved in the pathophysiology of temporal lobe epilepsy (TLE) are oxidative stress, inflammation, and pyroptosis. There are evidences indicating that acetyl-l-carnitine (ALC) has anti-oxidative, anti-inflammatory, and anti-pyroptotic effects. In the present study, rat model of TLE was induced by intrahippocampal kainate and animals received ALC (100 mg/kg, p.o.). ALC properly attenuated intensity of seizures and also incidence of kainate-induced status epilepticus (SE). As well, obtained findings showed that ALC can partially reverse hippocampal levels of MDA, ROS, SOD, TNFa, NF-kB, TLR4, GFAP, and caspase 1. Besides, treatment of kainate group with ALC exerted a protective effect against CA

Indexed as

Epilepsy, Temporal LobeStatus EpilepticusAcetylcarnitineAnimalsAnticonvulsantsDisease Models, AnimalHippocampusKainic AcidMiceRatsSeizuresAcetylcarnitineAnticonvulsantsKainic AcidAcetyl-l-carnitineInflammationKainateOxidative stressPyroptosis

Identifiers

PMID35320462
OpenAlexW4220907266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.